May-June 2025
Interventions and Assessments
- GLP1 Agonists Show Promise for Treating Substance Use Disorders
- Facilitation Program Increased Medication for Opioid Use Disorder Prescribing in Rural Primary Care Clinics
- Outpatient Low-dose Buprenorphine Initiation for Opioid Use Disorder Should Be Offered, but Has Low Rates of Treatment Completion and Retention
Health Outcomes
- Rates of Cannabis Use Disorder Associated With Schizophrenia and Psychosis Increased With Cannabis Legalization in Canada
- Stimulant Overdoses and Calls to Emergency Services Among Individuals With Recent Stimulant Use
- Fentanyl Exposure Not Associated With Perceived Adequacy of Methadone Dose